Utilize este identificador para referenciar este registo: http://hdl.handle.net/10400.18/2688
Título: Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13
Autor: Kissling, E.
Valenciano, M.
Buchholz, U.
Larrauri, A.
Cohen, J.M.
Nunes, Baltazar
Rogalska, J.
Pitigoi, D.
Paradowska-Stankiewicz, I.
Reuss, J.
Jiménez-Jorge, S.
Daviaud, I.
Guiomar, R.
O'Donnell, J.
Necula, G.
Głuchowska, M.
Moren, A.
Palavras-chave: Influenza
Vaccine
Effectiveness
Cuidados de Saúde
Data: 13-Fev-2014
Editora: ECDC-European Centre for Disease Prevention and Control
Citação: Euro Surveill. 2014 Feb 13;19(6). pii: 20701
Resumo: In the fifth season of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE), we undertook a multicentre case–control study (MCCS) in seven European Union (EU) Member States to measure 2012/13 influenza vaccine effectiveness against medically attended influenza-like illness (ILI) laboratory confirmed as influenza. The season was characterised by substantial co-circulation of influenza B, A(H1N1)pdm09 and A(H3N2) viruses. Practitioners systematically selected ILI patients to swab ≤7 days of symptom onset. We compared influenza-positive by type/subtype to influenza-negative patients among those who met the EU ILI case definition. We conducted a complete case analysis using logistic regression with study as fixed effect and calculated adjusted vaccine effectiveness (AVE), controlling for potential confounders (age, sex, symptom onset week and presence of chronic conditions). We calculated AVE by type/subtype. Study sites sent 7,954 ILI/acute respiratory infection records for analysis. After applying exclusion criteria, we included 4,627 ILI patients in the analysis of VE against influenza B (1,937 cases), 3,516 for A(H1N1)pdm09 (1,068 cases) and 3,340 for influenza A(H3N2) (730 cases). AVE was 49.3% (95% confidence interval (CI): 32.4 to 62.0) against influenza B, 50.4% (95% CI: 28.4 to 65.6) against A(H1N1)pdm09 and 42.2% (95% CI: 14.9 to 60.7) against A(H3N2). Our results suggest an overall low to moderate AVE against influenza B, A(H1N1)pdm09 and A(H3N2), between 42 and 50%. In this season with many co-circulating viruses, the high sample size enabled stratified AVE by type/subtype. The low estimates indicate seasonal influenza vaccines should be improved to achieve acceptable protection levels.
Peer review: yes
URI: http://hdl.handle.net/10400.18/2688
ISSN: 1560-7917
Versão do Editor: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20701
Aparece nas colecções:DEP - Artigos em revistas internacionais

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
art20701.pdf496,71 kBAdobe PDFVer/Abrir


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote Degois 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.